Frequently Asked Questions
I want to get the most out of my consult with Dr. Lawenda. What information will he need prior to my scheduled consult/follow up?
The cost is based on a 30-minute or 60-minute follow up or consult with Dr. Lawenda. You can find pricing information by visiting our Plans & Pricing page.
What tests are recommended for foundation information Dr. Lawenda thinks would be useful for cancer promoting physiological factors?
- Your nutrient status (Spectracell Micronutrient Test)
- Your insulin sensitivity/resistance (included in Spectracell Basic Lab Test)
- Your inflammation status (included in Spectracell Basic Lab Test)
- Your microbiome health (GI-MAP Stool Test)
- Your stress hormones, estrogen metabolites, methylation function and melatonin (DUTCH Assays)
Are there any medications, foods, conditions, or other factors that could interfere with the results of a Cyrex test?
Yes. While Cyrex is unable to provide an exhaustive answer to this question due to the interactive complexities and varieties of medications and circumstances, the following has been noted:
- Immunosuppressant and corticosteroid drugs can reduce antibody production and cause false negative results.
- A gluten-free diet can cause false negative results.
- Avoid eating a high fat meal prior to your blood draw to prevent your specimen being lipemic. Lipemic specimens are rejected by Cyrex Labs and recollection will be required.
What does it mean if my Spectracell Micronutrient Test is non-responsive due to insufficient lymphocyte proliferation?
Spectracell’s methodology involves growing cells under different nutritional conditions. Consequently, individuals with certain conditions or treatment regimens may be poor candidates for Spectracell nutritional testing, due to difficulties in obtaining or interpreting results for them. For a variety of reasons, cancer patients can be uniquely challenging patients for functional micronutrient testing:
1. Patients with blood borne proliferative disorders (e.g., leukemias, lymphomas, and invasive or metastatic cancers) have a population of cancerous cells mixed with their t-lymphocytes, which can make interpreting results problematic.
2. It may be difficult to obtain results during treatments that hinder cell growth (e.g., chemotherapies) or suppress immune function. There has been some success with testing chemotherapy patients between treatments (depending on the dosage and chemotherapeutic treatment, but there is an increased likelihood of test failure. Metabolic toxins and cell growth assays make for a poor combination.
3. Patients presenting with immunosuppression, immunodeficiency or severe inflammation may also show an increased likelihood of test failure (and all of these factors may be present in cancer patients). A minimum of 1600 cell/uL of lymphocytes is needed to perform the nutrition test, and Spectracell must reject submitted samples if the total WBC is greater than 20,000 cell/uL. An acceptable range of lymphocytes (including T-cells, B-cells, and natural killer (NK) cells) for testing purposes is between 15% and 40% of the total WBC count.
4. Patients with recent blood transfusions (3 months or more, depending on the number of units transfused) will also present a mixed cell population of the patient’s and the donor’s cells, which can make interpreting results problematic.
While Spectracell will do their utmost to attempt to provide high quality results for cancer patients, we feel that it’s important for clients to be informed of the greater likelihood of test failure and the possible challenges inherent in results interpretation under these circumstances.
Patients undergoing chemotherapy may want to perform nutritional testing just prior to treatment, or wait 4-6 weeks after their treatment is complete before submitting samples for nutrition testing to maximize the likelihood of successful testing.
If your test is found to be non-responsive, you will be contacted right away to discuss the next steps. This usually includes recollection which will be of no additional charge to you.
Yes, see below. If you are a resident of one of these states and are interested in testing, please reach out to us by emailing email@example.com to discuss your options.
- SPECTRACELL MICRONUTRIENT TEST: New York
- GENOVA MICRONUTRIENT TEST: New York
- GI-MAP STOOL TEST: New York
- DUTCH TESTS: New York, Rhode Island, Maryland
AboutDr. Brian Lawenda
In addition to being a radiation oncologist, integrative oncologist, and medical acupuncturist, Dr. Brian Lawenda is also the founder of Integrative Oncology Essentials, the medical director at Northwest Cancer Clinic/21st Century Oncology; and a clinical associate professor at Floyd College of Medicine, Washington State University.
After graduating from Temple University School of Medicine in Philadelphia, he completed his internship in general surgery with the Naval Medical Center San Diego, and later served his residency in radiation oncology at the Harvard Medical School, Massachusetts General Hospital. There, he was appointed chief resident of the Harvard Combined Radiation Oncology Program.